Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of SSP-004184AQ in transfusional iron overload
NCT01671111Phase 2Terminated
- Sponsor
- Takeda
- Start
- Aug 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of deferitazole in iron overload, sponsored by Takeda. Started Aug 2012; status: terminated.
02
Drugs
deferitazole
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01671111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01671111.